Echinocandin inhibition of 1,3‐β‐D‐glucan synthase from Candida albicans [PDF]
E.T. Sawistowska-Schröder +2 more
openalex +1 more source
Triazoles Versus Echinocandins for the First-Line Treatment of Invasive Pulmonary Aspergillosis: A Propensity Score-Weighted Multicenter Study. [PDF]
Hatzl S +9 more
europepmc +1 more source
In Vivo Comparison of the Pharmacodynamic Targets for Echinocandin Drugs against Candida Species
David R. Andes +5 more
openalex +1 more source
SCY-247, a novel second-generation triterpenoid antifungal, demonstrates high in vitro activity against genetically diverse Candida auris isolates, including FKS1 mutants. [PDF]
Spruijtenburg B, de Groot T, Meijer EFJ.
europepmc +1 more source
Ahmad Aljohani,1,2,* Saeed Alqahtani3,* 1Pharmaceutical Care Services, King Fahd General Hospital, Ministry of Health, Jeddah, Saudi Arabia; 2Department of Pharmacy, College of Pharmacy, Nursing and Medical Sciences, Riyadh Elm University, Riyadh,
Aljohani A, Alqahtani S
doaj
Diagnosis and management of invasive candidiasis in critically ill patients: SIAARTI multidisciplinary statement. [PDF]
Cortegiani A +13 more
europepmc +1 more source
Killing rates for caspofungin against Candida albicans after brief and continuous caspofungin exposure in the presence and absence of serum [PDF]
Berényi, Réka +6 more
core +1 more source
Treatment Options and Antifungal Resistance in Pediatric <i>Candidozyma auris</i> (Previously <i>Candida auris</i>) Infections: A Systematic Review of Clinical Outcomes. [PDF]
Stergiou K +10 more
europepmc +1 more source
Efficacy and safety of echinocandins combined with Trimethoprim-Sulfamethoxazole as first-line treatment for Pneumocystis pneumonia in HIV-infected and non-HIV-infected patients. [PDF]
Xie J, Gao A, Zhang W, Zhao D, Liu W.
europepmc +1 more source

